Parra Izquierdo Viviana, Cedron Hugo, Argollo Marjorie, Torres Joana, Ernest-Suárez Kenneth
Hospital Internacional de Colombia, Santander, Colombia; Universidad El Bosque, Bogotá, Colombia; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium.
Clínica Anglo Americana, Lima, Perú.
Rev Gastroenterol Peru. 2025 Apr-Jun;45(2):155-175.
In Latin America, the prevalence of Inflammatory Bowel Disease (IBD) has increased in recent years, creating a growing need for diagnostic tools both for its detection and for ongoing monitoring. Intestinal ultrasound (IUS) has become a well-established, non-invasive, accurate, and well-tolerated tool to evaluate IBD activity in real time-even during the same medical consultation. Available evidence supports its usefulness in accurately determining inflammatory activity and identifying associated complications. At the time of diagnosis and initiation of treatment, IUS has proven to be the ideal non-invasive study for close monitoring, assessing therapeutic response, and making early treatment adjustments. Multiple systematic reviews and meta-analyses have shown that its diagnostic accuracy is comparable to that of colonoscopy or magnetic resonance imaging. Additionally, IUS allows for therapeutic monitoring and prognosis assessment in a more accessible, non-invasive way, with greater patient adherence compared to other diagnostic modalities. This review article aims to analyze the optimal use of IUS and its current role in the management of patients with IBD.
在拉丁美洲，近年来炎症性肠病（IBD）的患病率有所上升，这使得对其检测和持续监测的诊断工具的需求日益增长。肠道超声（IUS）已成为一种成熟的、非侵入性的、准确的且耐受性良好的工具，可实时评估IBD活动——即使在同一次医疗咨询期间。现有证据支持其在准确确定炎症活动和识别相关并发症方面的有用性。在诊断和开始治疗时，IUS已被证明是用于密切监测、评估治疗反应和进行早期治疗调整的理想非侵入性检查。多项系统评价和荟萃分析表明，其诊断准确性与结肠镜检查或磁共振成像相当。此外，与其他诊断方式相比，IUS能够以更便捷、非侵入性的方式进行治疗监测和预后评估，患者依从性更高。这篇综述文章旨在分析IUS的最佳应用及其在IBD患者管理中的当前作用。
